Diabetes and obesity drug maker Novo Nordisk will invest "significantly" in its supply chain capacity to avoid future supply shortages, the company's CEO Lars Jorgensen told its annual general meeting...
Source LinkDiabetes and obesity drug maker Novo Nordisk will invest "significantly" in its supply chain capacity to avoid future supply shortages, the company's CEO Lars Jorgensen told its annual general meeting...
Source Link
Comments